Amryt Pharma
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Amryt Pharma generated cash of $15,531,000, which is less than the previous year. Cash used in financing activities reached the amount of -$125,426,000 last year. Net change in cash is therefore -$5,766,000.
Cash Flow
| 2012 | -395.44K | 632.39K | 0 |
|---|---|---|---|
| 2013 | -1.07M | -4.12M | 34.65M |
| 2014 | -2.06M | -27.18M | 14.97M |
| 2015 | -3.79M | 3.15M | 0 |
| 2016 | -6.42M | 2.58M | 12.35M |
| 2017 | -14.23M | -379.10K | 29.20M |
| 2018 | -14.94M | -242.50K | 3.17M |
| 2019 | -37.49M | 24.42M | 65.94M |
| 2020 | 26.89M | -2.37M | 26.02M |
| 2021 | 15.53M | 106.40M | -125.42M |
AMYT Cash Flow Statement (2012 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 118.79M | 67.22M | 11.22M | 23.46M | 9.92M | 179.84K | 17.42M | 31.53M | 981.52K | 1.6K |
Operating activities | ||||||||||
Net income | -18.17M | -104.52M | -65.53M | -29.48M | -31.35M | -8.20M | -39.93M | -2.93M | -3.50M | -826.11K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 50.74M | 44.46M | 12.65M | 354.60K | 310.72K | 204.03K | 6K | 6K | 4.55K | 0 |
Stock-based compensation expense | 8.34M | 4.72M | 841K | 793.86K | 677.83K | 240.83K | 129K | 464K | 392.00K | 0 |
| Deferred income tax benefit | 8.34M | 4.72M | 841K | 793.86K | 677.83K | 240.83K | 129K | 464K | 392.00K | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | -13.28M | -10.60M | -5.89M | -897.96K | -375.50K | -87.29K | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | 15.53M | 26.89M | -37.49M | -14.94M | -14.23M | -6.42M | -3.79M | -2.06M | -1.07M | -395.44K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -1.54M | -2.46M | -652K | -228.78K | -395.90K | -12.62K | -17.44M | -7K | -15.19K | 0 |
Acquisitions Net | 107.94M | 0 | 24.98M | 0 | 0 | -10.02M | 0 | 0 | -919.22K | 0 |
Cash generated by investing activities | 106.40M | -2.37M | 24.42M | -242.50K | -379.10K | 2.58M | 3.15M | -27.18M | -4.12M | 632.39K |
Financing activities | ||||||||||
Common Stock Issued | 4.70M | 37.92M | 63.00M | 0 | 17.26M | 11.83M | 0 | 14.97M | 35.68M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -117.84M | -1.11M | 0 | 0 | 0 | -49.42K | 0 | 0 | -1.03M | 0 |
Cash used in financing activities | -125.42M | 26.02M | 65.94M | 3.17M | 29.20M | 12.35M | 0 | 14.97M | 34.65M | 0 |
Net Change In Cash | -5.76M | 51.56M | 56.00M | -12.24M | -1.57M | 8.51M | -638K | -14.11M | 30.52M | 236.94K |
Cash at end of period | 113.03M | 118.79M | 67.22M | 11.22M | 8.34M | 8.69M | 16.79M | 17.42M | 31.50M | 238.54K |
| Data source | Data source |